![]() | The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations .(August 2021) |
![]() | |
Established | 1999 |
---|---|
Chairperson | Lewis S Ranieri, Scott Rechler |
President | Kevin J. Tracey |
Vice-chair | Jack J. Ross |
Total staff | 5,000 [1] |
Location | , , United States |
Website | feinstein |
The Feinstein Institutes for Medical Research in Manhasset, New York, United States, on Long Island, is the research home of Northwell Health. [2] Feinstein Institutes is home to 50 research labs, 2,500 clinical research studies, and 5,000 professional and support staff. [3] [4] The faculty includes a members of the National Academy of Sciences, the National Academy of Medicine, the American Society for Clinical Investigation, and the Association of American Physicians. Feinstein Institutes' scientists conduct research in molecular medicine, genetics, cancer, neuroscience, behavioral science, and bioelectronic medicine, among others. Feinstein Institutes is the laboratory and faculty home of the Elmezzi Graduate School of Molecular Medicine. Students with an MD degree may earn a PhD in molecular medicine.
The Feinstein Institutes was established in 1999 as The Institute for Medical Research at North Shore-LIJ, [5] acquiring assets from the Picower Institute for Medical Research when it ceased operations. [6] [7] [8] The Institutes are research home of the North Shore-Long Island Jewish Health System, which rebranded as Northwell Health in 2015. [5]
In 2003, U.S. Senator Hillary Clinton presented the North Shore-LIJ General Clinical Research Center (now known as Feinstein Institutes) with a $15 million grant from the National Institutes of Health. [9] [10]
Board member Leonard Feinstein, co-founder of Bed Bath & Beyond, made a $25 million gift that led to the institute being renamed as The Feinstein Institutes for Medical Research in 2005. [5] That same year, Kevin J. Tracey, MD was appointed President of the Feinstein Institutes and took the place of CEO in January 2006. [5] [11] In 2017, Feinstein and his wife, Susan, committed another $25 million to the Institutes. [12]
Feinstein publishes two open-access, international peer-reviewed medical journals in partnership with BioMed Central , part of Springer Nature : Molecular Medicine and Bioelectronic Medicine .
Beginning in 2013, the Feinstein Institutes annually bestow two major academic awards: the Anthony Cerami Award in Translational Medicine and the Ross Prize in Molecular Medicine. [13] Most notably, the 2022 Ross Prize winners were Katalin Kariko, PhD and Drew Weissman, MD, PhD, both of whom were awarded the 2023 Nobel Prize in Physiology or Medicine. In conjunction with the prize, the Institutes host an annual Ross Prize in Molecular Medicine Symposium where the winner presents the keynote lecture. [14]
In 2022, the National Institutes of Health (NIH), granted the Institutes $3.8 million to study the effects of radiation on the body’s immune system. This research was led by the Institutes’ co-principal investigators Dr. Ping Wang, Dr. Max Brenner, and Dr. Monowar Aziz. Dr. Ping Wang received an additional $2.5 million from the NIH to further his research on sepsis. [15]
In April 2024, the Feinstein Institutes were awarded a grant of $6.1 million from the NIH for three research projects on red cell disorders. [16]
In July 2024, the Feinstein Institutes for Medical Research hosted its 19th annual Summer Concert, headlined by Gwen Stefani. The event raised $3.6 million to support scientific discovery. [17]
In 2024, Feinstein Institutes for Medical Research comprises the following six [18] institutes:
Feinstein has the standard support services and scientific cores to support basic research. [20] Support includes:
The cores include:
In 2016, the Feinstein Institutes for Medical Research agreed to pay the U.S. Department of Health and Human Services, Office for Civil Rights (OCR), $3.9 million to settle potential violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) privacy and security rules and to undertake a substantial corrective action plan to bring its operations into compliance. [21]